Journals By Industry - Dermatology

Acne is the most common skin disorder in the United States, affecting up to 50 million people, according to the American Academy of Dermatology. It's so widespread that by their mid-teens, more than...

- Additional End-of-Phase 2 Meeting Not Required- -Company to Submit for Special Protocol Assessment- KNOXVILLE, Tenn. -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has received guidance...

Program Provides Individuals the Opportunity to Learn from Leading Lupus Experts WASHINGTON -- The Lupus Foundation of America (LFA) has announced its 2012 topics and dates for its nationwide education series, Lupus: Learn...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/8f5a37/dermatology_therap) has announced the addition of the "Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and...

KNOXVILLE, Tenn. -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announced today that Craig Dees, Ph.D., CEO, will present at BOCEMb: Noble Financial Capital Markets' Eighth Annual...

KNOXVILLE, Tenn. -- Provectus Pharmaceuticals, Inc. (OTCBB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, announces that nonclinical data on the immunologic mechanism of action of PV-10 will be presented at the...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/c7e9f8/hong_kong_pharmace) has announced the addition of the "Hong Kong Pharmaceuticals and Healthcare Report Q1 2012" report to their offering. Hong Kong continues to be viewed as a moderately...

ATLANTA -- Dynasty Healthcare, a leading outsourced medical billing firm, announced today a strategic partnership with Triton Value Partners, a business advisory and investment firm. Triton will advise Dynasty on the expansion of...

SARASOTA, Fla. -- The results of a study published in Nutrition Journal are good news for emerging nutraceuticals provider Neutra Corp. (OTCBB:NTRR): Up to 91 percent of U.S. physicians recommend nutritional dietary supplements...

Four Patents Continue the Expansion of Company's Industry Leading Peptide Portfolio BOTHELL, Wash. -- Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced that it has been granted four new...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/5fb90b/endpoints_clinic) has announced the addition of the "Endpoints - Clinical Trials in Dermatology - Inflammatory Lesions Count is the Key Determinant of Success in Acne Vulgaris Clinical Trials"...

ATLANTA -- Georgia Bio announced its 2012 Deals of the Year for pharmaceutical, biopharmaceutical and medical device companies in four categories - public and private financings, fast growing companies, acquisitions and SBIR grants...

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/2bd809/genentech_inc_c) has announced the addition of iCD Research's new company profile "Genentech, Inc.: Company Profile and SWOT Analysis" to their offering. Key Highlights Genentech, Inc. (Genentech) is among...

CINCINNATI -- Now you can "Live in Your Best Light," as Lasya, Incorporated announces the launch of its first product, Lanterna(TM), a cosmetic cream containing 3% deoxyArbutin (dA). dA, originally developed by Lasya...

Founder of Hevia Cosmetic Dermatology and the skin care line Hevia Skin ScienceO Ingredients with a Purpose[TM] is recognized internationally for innovative techniques, notable natural results, and extensive research in the field of...

New rehabilitation center set to open January 16 APPLE VALLEY, Minn. -- A new Sister Kenny Sports & Physical Therapy Center will open January 16 at the Apple Valley Medical Center, located at...

Strengths One of the largest pharmaceutical companies in Israel. Strong position of generic drugs on the local market. Diverse product portfolio. Presence in the US through an affiliate company. Weaknesses Unattractive domestic market....

Strengths Well-established market presence in Singapore. A strong product portfolio, including transplantation and immunology, oncology, cardiovascular diseases, central nervous system (CNS) disorders, endocrine, gastrointestinal, dermatology and ophthalmic treatments. One of the fastest-growing global...

Strengths Novartis has capital strength and a diverse business portfolio, comprising ethical drugs, OTCs, eyecare and infant products. Sandoz generic drugs division is well placed to exploit any expansion in the country's legitimate...